-transparent.png){kind=logo}
The authors have evaluated the effects of specific Immunoglobulins administration in order to prevent type B viral hepatitis. 34 members of care units entered a program of epidemiological surveillance after an occasional contamination with biological samples obtained from patients affected by type B viral hepatitis. All these subjects have been treated with two injections of specific immunoglobulins at the dose of 0.06 ml/kg. i.m.; the first was administered immediately after contamination and the second after one month. Serum antibody titres were determined by RIA techniques in a six months follow-up. The results seem to indicate that the degree of protectivity after passive immunization is poor and rather incostant.
S Corridori, and
P Gorini, and
G Trespi, and
E Baldini
February 1980,
Bollettino della Societa italiana di biologia sperimentale,
S Corridori, and
P Gorini, and
G Trespi, and
E Baldini
January 1991,
Research in virology,
S Corridori, and
P Gorini, and
G Trespi, and
E Baldini
January 1995,
Presse medicale (Paris, France : 1983),
S Corridori, and
P Gorini, and
G Trespi, and
E Baldini
December 2016,
Medicine,
S Corridori, and
P Gorini, and
G Trespi, and
E Baldini
September 1948,
The Journal of laboratory and clinical medicine,
S Corridori, and
P Gorini, and
G Trespi, and
E Baldini
July 1979,
Bollettino dell'Istituto sieroterapico milanese,
S Corridori, and
P Gorini, and
G Trespi, and
E Baldini
January 1973,
Infection,
S Corridori, and
P Gorini, and
G Trespi, and
E Baldini
November 1998,
Journal of immunoassay,
S Corridori, and
P Gorini, and
G Trespi, and
E Baldini
December 1973,
Revue medicale de Liege,
S Corridori, and
P Gorini, and
G Trespi, and
E Baldini
April 1993,
Proceedings of the National Academy of Sciences of the United States of America,
